HOMBACH ROBERT J.

CIK 00014961828 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001496182

Recent Transactions

50 trades

Purchase
Seaport Therapeutics, Inc.$SPTX
Common Stock
2026-06-22$18.14/sh+13,000→ 13,000 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2026-06-02+7,490→ 49,360 total
Award
Seaport Therapeutics, Inc.$SPTX
Stock Option (Right to Buy)
2026-04-30+12,258→ 12,258 total
Award
HENRY SCHEIN INC$HSIC
Common Stock par value $0.01 per share
2026-03-06+2,577→ 5,421 total
Award
Embecta Corp.$EMBC
Common Stock
2026-02-11+22,841→ 64,587.208 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2025-05-20+6,650→ 41,870 total
Award
HENRY SCHEIN INC$HSIC
Common Stock par value $0.01 per share
2025-03-04+2,844→ 2,844 total
Award
Embecta Corp.$EMBC
Common Stock
2025-02-12+13,839→ 39,749.197 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-05-21+4,720→ 35,220 total
Award
Embecta Corp.$EMBC
Common Stock
2024-02-07+11,455→ 24,903.902 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2023-05-23+4,190→ 30,500 total
Award
Embecta Corp.$EMBC
Common Stock
2023-02-09+6,979→ 13,074.823 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2022-05-26+40,000→ 40,000 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2022-05-24+4,980→ 26,310 total
Award
Embecta Corp.$EMBC
Common Stock
2022-04-01+6,024→ 6,024 total
Purchase
Aptinyx Inc.
Common Stock
2021-11-12$2.40/sh+74,600→ 219,100 total
Purchase
Aptinyx Inc.
Common Stock
2021-11-12$2.40/sh+74,600→ 229,100 total
Purchase
Aptinyx Inc.
Common Stock
2021-11-11$2.40/sh+5,400→ 144,500 total
Purchase
Aptinyx Inc.
Common Stock
2021-11-11$2.40/sh+5,400→ 154,500 total
Award
CARMAX INC$KMX
Common Stock
2021-07-02+1,308→ 7,766 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2021-05-27+40,000→ 40,000 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2021-05-25+5,120→ 21,330 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2020-12-31$2.22/sh+5,620→ 5,620 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2020-09-30$2.16/sh+5,779→ 5,779 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2020-06-30$2.68/sh+4,669→ 4,669 total
Award
CARMAX INC$KMX
Common Stock
2020-06-26+2,021→ 6,458 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2020-05-27+4,300→ 16,210 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2020-05-20+40,000→ 40,000 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2020-03-31$1.36/sh+9,218→ 9,218 total
Purchase
Aptinyx Inc.
Common Stock
2020-01-10$3.00/sh+50,000→ 139,100 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2019-12-31$2.14/sh+5,835→ 5,835 total
Purchase
Aptinyx Inc.
Common Stock
2019-11-22$3.23/sh+50,000→ 89,100 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2019-09-30$2.08/sh+6,002→ 6,002 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2019-06-28$1.98/sh+6,307→ 6,307 total
Award
CARMAX INC$KMX
Common Stock
2019-06-28+2,020→ 4,437 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2019-06-04+4,430→ 11,910 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2019-05-15+40,000→ 40,000 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2019-03-29$2.42/sh+5,154→ 5,154 total
Purchase
Aptinyx Inc.
Common Stock
2019-01-25$5.54/sh+11,655→ 49,100 total
Purchase
Aptinyx Inc.
Common Stock
2019-01-24$5.52/sh+13,345→ 37,445 total
Award
CARMAX INC$KMX
Common Stock
2018-06-29+2,390→ 2,417 total
Purchase
Aptinyx Inc.
Common Stock
2018-06-25$16.00/sh+24,100→ 24,100 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2018-06-05+4,300→ 7,480 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2017-09-29+3,180→ 3,180 total
Disposition to Issuer
Baxalta Inc
Common Stock, par value $0.01 per share
2016-06-03−209,089→ 0 total
Disposition to Issuer
Baxalta Inc
Stock Option (Right to Buy)
2016-06-03−88,597→ 0 total
Disposition to Issuer
Baxalta Inc
Stock Option (Right to Buy)
2016-06-03−380,535→ 0 total
Award
Baxalta Inc
Common Stock, par value $0.01 per share
2016-06-03+16,356→ 209,089 total
Disposition to Issuer
Baxalta Inc
Stock Option (Right to Buy)
2016-06-03−49,628→ 0 total
Disposition to Issuer
Baxalta Inc
Stock Option (Right to Buy)
2016-06-03−95,163→ 0 total

Companies

Recent Filings

Address

SEAPORT THERAPEUTICS, INC. 101 SEAPORT BLVD., FLOOR 12

BOSTON, MA, 02210

View on SEC.gov